FDA Approved: DALVANCE — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved the original application for Dalvance (dalbavancin) by Allergan, Inc., for the treatment of acute bacterial skin and skin structure infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Dalvance (dalbavancin)

Snippet

ORIG AP for DALVANCE (DALBAVANCIN)